76 results about "Novel treatment method" patented technology

The invention discloses a method for desizing cotton grey cloth, which is a novel treatment method comprising the following steps: first using plasma equipment blocked by a medium to treat the cotton grey cloth, singeing, boiling-off with low chemical concentration in a short time and finally bleaching, i.e. plasma->singeing->half-boiling-off (or omitting boiling-off)-bleaching; and the capillary effect, the breaking strength, the white content and the like of the semi-finished cloth after treatment are close to those of the semi-finished cloth treated by conventional production methods, and the alkali boiling-off concentration and steaming time thereof are one third lower than those of the semi-finished cloth treated by the conventional production methods. The method can be used for the pre-treatment of the cotton grey cloth, and achieves the purposes of saving energy and reducing emission.

The invention discloses applications of miR-455-3p in the diagnosis, treatment, and prognosis of esophageal squamous cancer. The inventor finds that the obviously low survival rate of ESCC patients is related with the high expression of miR-455-3p in ESCC patients. The in-vitro and in-vivo experiment results show that miR-455-3p is capable of promoting the malignant progression of ESCC, by inhibiting the expression of miR-455-3p, the ESCC stem cell characteristics can be inhibited, and the sensitivity of ESCC stem cells to chemotherapy drugs is enhanced; so an expression inhibitor of miR-455-3p can inhibit the tumor stem cells, and is capable of inhibiting the tumor stem cell characteristics and enhancing the sensitivity of the cancer stem cells to chemotherapy drugs. The invention finds the expression of miR-455-3p in cancer patients for the first time, and the expression can be used as auxiliary diagnosis and/or prognosis of ESCC. The invention provides a novel diagnosis method, a novel treatment method, and a pharmaceutical drug screening platform for tumor diseases.

The invention provides a method for recycling vanadium in waste containing vanadium. The method comprises the steps that the waste containing the vanadium and materials containing vanadium are mixed to obtain premixed materials; after the premixed materials are crushed, a mixed material is obtained; an additive and a humidification agent of a certain proportion are added into the mixed material, and the mixed material is put into a rotary kiln to be roasted to obtain a roasted clinker; and after the roasted clinker is taken out of the kiln, leaching liquid is added into the roasted clinker to obtain a solution containing the vanadium, and the obtained solution containing the vanadium can be refined to be various vanadium products as needed. By means of the method, not only is the recovery rate of metal vanadium in a vanadium production system improved and the storage of the waste containing the vanadium achieved, but also the novel treatment method is provided for solid hazardous waste containing vanadium on the premise of not additionally arranging novel equipment.

The present invention relates to novel antibody-based treatment methods, which comprise the use of antibodies with high affinity combined with high potency, particularly the use of antibodies against a particular epitope.

The invention relates to a method for carrying out biological modification upon erythromycin bacteria residue and for reusing the modified product in fermentations of antibiotics such as erythromycin or macrolide. According to the erythromycin bacteria residue biological modification method, erythromycin bacteria residue and other industrial and agricultural by-products are adopted as substrates; a selective mixed flora is inoculated; compound enzyme preparation solid-state fermentation is carried out; and steps such as drying, crushing, sieving, packaging and the like are carried out. The treatment method provided by the invention has the characteristics of simple production process, easy operation, short treatment time, and high treatment efficiency. Compared with the original bacteria slag (with protein content of 17-25% and ash content of 21-27%), the protein content of the modified product (with protein content no lower than 28% and ash content no higher than 15%) is increased by 12-65%, and an ash content is reduced by 29-44%. The product can be reused as a fermentation medium for antibiotics such as erythromycin or macrolide, and fermentation titer can be improved. The invention provides a novel approach for solving problems of environment pollution and waste recycling in erythromycin production.

The invention discloses a novel treatment method for a nano precipitation strengthened CoCrNi-based high-entropy alloy, and relates to the technical field of high-entropy alloys. The novel treatment method comprises the following steps that after an as-cast CoCrNi-based high-entropy alloy is subjected to homogenizing annealing for 1.5-3 h at the temperature being 1150-1250 DEG C, first-time machining deformation thinning is conducted till the thickness is 30-60% of that of the as-cast alloy, then recrystallization treatment is conducted for 8-15 min at the temperature being 1150-1250 DEG C, second-time machining deformation thinning is conducted till the thickness is 70-85% of that of the alloy subjected to first-time machining deformation, then aging treatment is conducted for 12-20 h at the temperature being 650-850 DEG C, and the strengthened CoCrNi-based high-entropy alloy is obtained. The room temperature rolling process is adopted twice in the mechanical heat treatment process of the CoCrNi-based high-entropy alloy, compared with an existing process, the strengthening effect is remarkable, the yield strength is improved by 400 MPa or above, and the maximum tensile strength is improved by 300 MPa or above.

Provided is a medical material which enables a novel treatment method for cartilage regeneration being different from a treatment method through transplantation of autologous cartilage, a cartilage alternative or undifferentiated cells. Provided is a bone-filling type agent for inducing cartilage regeneration comprising a hydrogel which contains, as a monomer unit, an acid having an acidic group and/or a salt obtained by adding a metal to an acidic group and does not contain an interpenetrating network structure or a semi-interpenetrating network structure composed of two or more polymers. The bone-filling type agent for inducing cartilage regeneration can induce natural cartilage regeneration in the body by filling it in a hole or a groove provided in subchondral bone beneath cartilage defect.

The invention provides a novel aluminum metal surface treatment method and an aluminum metal shell. The treatment method adopts the steps of degreasing, alkali etching, ash removal, anodic oxidation and N treatment to treat the aluminum metal surface. In the step, using N1 agent, N2 agent, N3 agent, N4 agent and N5 agent in order to perform N treatment on the surface of the aluminum metal that has been anodized, the aluminum metal shell includes an aluminum base, and is arranged on the aluminum The barrier layer on the surface of the substrate and the oxide film layer arranged on the surface of the barrier layer, the oxide film layer contains nanopores. Compared with the related art, the aluminum metal surface treated by the aluminum metal surface treatment method provided by the present invention has uniform nanopore size, good gloss, high-quality oxide film, and simple process steps.

The invention provides a nucleotide sequence encoding a CAR (Chimeric Antigen Receptor) and an ROBO1 CAR-NK cell expressing the CAR. The ROBO1 CAR-NK cell provided by the invention specifically killstumor cells by applying an ROBO1 antibody to the construction of a CAR-NK cell which takes an ROBO1 molecule as a target antigen. The ROBO1 CAR-NK cell can be taken as a medicament for treating tumordiseases, is used for treating tumors with high expression of the ROBO1 molecules, is free from undesirable phenomena such as cytokine storm, and provides a novel treatment method for tumors which cannot be treated with traditional surgery, chemotherapy and radiotherapy; moreover, the ROBO1 CAR-NK cell has the advantages of small toxic and side effects, high safety and better killing effect compared with an ROBO1 CAR-T cell.

The invention discloses a high-salt organic pigment production wastewater treatment method, which includes the following steps: conveying high-salt organic pigment wastewater to a regulating tank through a pipeline, and fully and uniformly mixing the wastewater; and entering, by an effluent, from the regulating tank into an electro-catalytic oxidation system through the action of a pump, entering,by the effluent, from the electro-catalytic oxidation system into a hydrolytic acidification system, adsorbing, condensing and degrading organic matters in a water body by a cultured domesticated bio-film and bottom sludge, sinking, by insoluble matters in the water, to the bottom, flowing, by a supernatant fluid, out after being collected by a top water collecting groove, entering, by the effluent, from the hydrolytic acidification system into a CMBR system through the action of the pump, and reacting the hydrolyzed acidified wastewater through a bio-reactor, wherein the organic matters areoxidized and decomposed under the action of high-concentration mixed activated sludge to complete wastewater treatment. Compared with the prior art, the electro-catalytic oxidation system has higher efficiency and can remove most harmful substances in most wastewater to a certain extent, so that the toxicity of the wastewater is greatly reduced.

The invention discloses a resource utilization method of sludge biogas residue. The resource utilization method comprises the steps that a flocculating agent is added to raw sludge from a sewage plantfor dehydration to obtain dehydrated sludge; the obtained dehydrated sludge is subjected to anaerobic digestion treatment to obtain digested sludge and generate biogas; the obtained digested sludge is dried, and obtained solid sludge biogas residue is subjected to low-temperature pyrolysis to obtain pyrolytic carbon; and the sludge biogas residue pyrolytic carbon is added to the dehydrated sludgefor anaerobic digestion treatment. According to the resource utilization method of the sludge biogas residue, the dehydrated sludge is subjected to anaerobic digestion treatment, so that centralizedtreatment of municipal sludge is facilitated, reduction of the sludge is realized, problems of existing anaerobic digestion sludge treatment are solved, and a new method is created; and by optimizingan anaerobic digestion treatment process of a sewage treatment plant, a novel treatment method for sludge treatment stabilization and reduction is provided, the effect of anaerobic digestion treatmentof the sludge is improved, the degree of stability of heavy metal pollutants is improved, "pollution control by pollution" cyclic utilization of resources is achieved, and the sludge production rateis reduced.

The invention discloses a tissue-engineered dental pulp-dentin complex. The tissue-engineered dental pulp-dentin complex is constructed by dental pulp stem cells modified by PDGF-BB (Platelet-Derived Growth Factor-BB) genes, and is prepared by the following steps: (1) transfecting dental pulp stem cells which are cultured separately in vitro by using the PDGF-BB genes; (2) loading a product obtained in the step (1) onto a biological scaffold material to construct the engineered dental pulp-dentin complex. The tissue-engineered dental pulp-dentin complex has the advantages that multiplication of the dental pulp stem cells, differentiation of grown dents and secretion of grown blood vessel inducible factors can be facilitated by PDGF-BB, and the recruitment of stem cells can be facilitated to accelerate the growth of dents; in a nude mouse subcutaneous ectopic grown dent model, the mass of regenerated dentins is increased remarkably in an experimental group of dental pulp stem cells modified by PDGF-BB. The application advantages of the dental pulp steam cells modified by PDGF-BB in the regeneration of the dental pulp-dentin complex are verified, and a novel treatment method is provided for the problem of tooth regeneration.

Novel etiology and pathogenesis of premenstrual headache and premenstrual migraine are presented and novel treatment methods are provided. Present invention identifies how declining estrogen results in a transient elevation in extracellular calcium concentrations via osteoclast upregulation. The elevated extracellular calcium pathogenesis is then traced, from bone to brain, and includes depolarization of nerves, hyperactive neurotransmitter release, and hyperactive muscle contractility. Treatment methods are provided that target the earliest steps of the underlying etiology, in order to provide the most efficacious treatment possible. The treatment methods presented include use of compounds such as calcitonin and SERMs such as raloxifene.

The invention discloses a low temperature pressing extraction technology for peony seed oil production. A main solvent adopted in the low temperature pressing extraction technology for the peony seedoil production is butane. Main equipment of the low temperature pressing extraction technology for the peony seed oil production is a huller, a winnowing machine, a seed dryer, a screening machine, ahusking machine, a crusher, an extraction tank, an evaporation tank, a solvent storage tank and a compressor. A novel treatment method is adopted in the low temperature pressing extraction technologyfor peony seed oil production to cause the particle diameter of peony seed kernels to be appropriate and ensure that a butane solvent can fully extract the peony seed kernels at a low temperature; andthe technological process has high degree of automation. The pressure in an extraction vessel and a separation vessel is only 0.1MPa. The manufacturing cost of vacuuming equipment with the pressure reaching 0.1MPa, an extraction tank and a separation vessel which can be sealed at the pressure of 0.1MPa is relatively low. The procurement, operation and maintenance cost of overall equipment is relatively low. The low temperature pressing extraction technology is suitable for large-scale production.

The invention relates to a combined drug, comprising a certain amount of nicotinamide phosphoribosyltransferase (NAMPT) depressor and a certain amount of NQO1 substrate. The NAMPT depressor and the NQO1 substrate have synergistic effects in the anti-tumor process, and the action of the composition in the case of combined utilization of the NAMPT depressor and the NQO1 substrate is superior to the superposition when all the drugs are independently used. The combined drug can be applied to treatment of the non-small cell lung cancer and other cancers. Therefore, a novel treatment method for treating the non-small cell lung cancer is provided by the invention.